JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB155088

Anti-UBC4 antibody [EPR11031(B)]

Be the first to review this product! Submit a review

|

(6 Publications)

Rabbit Recombinant Monoclonal UBC4 antibody. Suitable for WB and reacts with Human samples. Cited in 6 publications.

View Alternative Names

PUBC1, UBC4, UBC5B, UBCH4, UBCH5B, UBE2D2, Ubiquitin-conjugating enzyme E2 D2, (E3-independent) E2 ubiquitin-conjugating enzyme D2, E2 ubiquitin-conjugating enzyme D2, Ubiquitin carrier protein D2, Ubiquitin-conjugating enzyme E2(17)KB 2, Ubiquitin-conjugating enzyme E2-17 kDa 2, Ubiquitin-protein ligase D2, p53-regulated ubiquitin-conjugating enzyme 1

2 Images
Western blot - Anti-UBC4 antibody [EPR11031(B)] (AB155088)
  • WB

Unknown

Western blot - Anti-UBC4 antibody [EPR11031(B)] (AB155088)

All lanes:

Western blot - Anti-UBC4 antibody [EPR11031(B)] (ab155088) at 1/1000 dilution

Lane 1:

MCF7 cell lysate at 10 µg

Lane 2:

HeLa cell lysate at 10 µg

Lane 3:

293T cell lysate at 10 µg

Lane 4:

Human fetal brain lysate at 10 µg

Secondary

All lanes:

Goat anti-rabbit HRP at 1/2000 dilution

Predicted band size: 16 kDa

false

Western blot - Anti-UBC4 antibody [EPR11031(B)] (AB155088)
  • WB

CiteAb

Western blot - Anti-UBC4 antibody [EPR11031(B)] (AB155088)

UBC4 western blot using anti-UBC4 antibody [EPR11031(B)] ab155088. Publication image and figure legend from Shi, Y., Yuan, B., et al., 2017, Nat Commun, PubMed 28469175.

ab155088 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab155088 please see the product overview.

Ub2D3 and Ube2N are required for RIG-I and MAVS activation on virus infection in HEK293T cells.(a,b) The cell-free assay containing vRNA and purified components (E1, Ub, RIG-I and Riplet) was performed as described in Fig. 2b, except that S100 fraction was substituted with purified E2 recombinant proteins as indicated. Each E2 protein was analysed at three different concentrations. Lane 13 did not contain E2 proteins (-E2). (c) HEK293T cells (wild-type and knockout lines) were transfected with or without si-Ube2D3 RNAs. Seventy two hours after transfection, the cells were infected with VSV. Twelve hours post virus infection, the cells were collected for measuring IFN induction by qPCR. *p<0.05 and ***p<0.001. (d,e) Cells were treated as described in c. P5 fractions were isolated to examine MAVS aggregation (d), and whole cell lysate were used to analyse knockdown or knockout effect in genes as indicated (e). The original full blot for (e) can be found in Supplementary Fig. 8d. (f) si-Ube2D3 RNAs were transfected into HEK293T (Ube2N-/-) cells. Seventy two hours after siRNA transfection, the cells were further transfected with pcDNA-flag-Ube2D3 or pcDNA-flag-Ube2N as indicated. Twenty four hours after transfection of pcDNA plasmids, the cells were infected with VSV for another twelve hours. The cells were then collected for analysis of MAVS aggregation. See also Supplementary Fig. 3f.

false

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR11031(B)

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>" }, "Mouse": { "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Rat": { "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purity
Tissue culture supernatant
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

UBC4 also known as Ubiquitin Conjugating Enzyme E2 D2 (Ube2d2) is an important component in the ubiquitination process. It weighs approximately 17.7 kDa and plays a pivotal role in labeling proteins for degradation by the proteasome. UBC4 is involved in catalyzing the transfer of activated ubiquitin from the E1 activating enzyme to a substrate protein. It is expressed in a wide range of tissues showing particularly high levels in testis and skeletal muscle. This wide expression pattern indicates a fundamental role in diverse cellular functions.
Biological function summary

UBC4 serves an important function in the regulation of protein homeostasis. It operates within the ubiquitin-proteasome system an essential cellular machinery that controls protein turnover. Although UBC4 acts independently it frequently associates with E3 ligases to target specific proteins for degradation. The enzyme thereby helps in maintaining cellular protein levels and regulating processes like cell cycle stress response and signal transduction.

Pathways

The ubiquitination mechanism involving UBC4 is critical in the cell cycle and stress response paths. In the cell cycle pathway UBC4 partners with relevant E3 ligases to ensure timely degradation of cyclins and other regulatory proteins facilitating proper cell division. In the stress response pathway UBC4 further collaborates with proteins such as HSP70 and HSP90 addressing damaged or misfolded proteins aiding cellular recovery from various stresses.

UBC4 exhibits significant connections to neurodegenerative disorders and cancers. In neurodegenerative conditions like Parkinson’s disease the malfunction of the ubiquitin-proteasome system contributes to protein aggregation and neuronal death. UBC4's role in these mechanisms makes it a critical factor in understanding the disease progression alongside proteins such as parkin and α-synuclein. In cancers irregularities in ubiquitination pathways involving UBC4 may lead to the persistence of oncoproteins and uncontrolled cellular proliferation highlighting its relevance to p53 and MDM2-associated pathways.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins (PubMed : 10329681, PubMed : 18042044, PubMed : 18703417, PubMed : 20061386, PubMed : 20403326, PubMed : 20525694, PubMed : 26475854, PubMed : 28322253). Catalyzes 'Lys-48'-linked polyubiquitination (PubMed : 10329681, PubMed : 18042044, PubMed : 18359941, PubMed : 18703417, PubMed : 20061386, PubMed : 20403326, PubMed : 20525694, PubMed : 26475854). Mediates the selective degradation of short-lived and abnormal proteins (PubMed : 10329681, PubMed : 18042044, PubMed : 18359941, PubMed : 18703417, PubMed : 20061386, PubMed : 20403326, PubMed : 20525694, PubMed : 26475854). Functions in the E6/E6-AP-induced ubiquitination of p53/TP53 (PubMed : 15280377). Mediates ubiquitination of PEX5 and SQSTM1 and autoubiquitination of STUB1 and TRAF6 (PubMed : 18359941, PubMed : 28322253). Involved in the signal-induced conjugation and subsequent degradation of NFKBIA, FBXW2-mediated GCM1 ubiquitination and degradation, MDM2-dependent degradation of p53/TP53 and the activation of MAVS in the mitochondria by RIGI in response to viral infection (PubMed : 18703417, PubMed : 20403326). Essential for viral activation of IRF3 (PubMed : 19854139).
See full target information UBE2D2

Publications (6)

Recent publications for all applications. Explore the full list and refine your search

Journal of neurochemistry 168:2479-2494 PubMed38497582

2024

Chronic social defeat stress induces the down-regulation of the Nedd4L-GLT-1 ubiquitination pathway in the prefrontal cortex of mice.

Applications

Unspecified application

Species

Unspecified reactive species

Aika Kosuge,Kazuo Kunisawa,Tsubasa Iida,Bolati Wulaer,Tomoki Kawai,Moeka Tanabe,Kuniaki Saito,Toshitaka Nabeshima,Akihiro Mouri

Journal of cell science 136: PubMed37226882

2023

The E2 ubiquitin-conjugating enzymes UBE2D1 and UBE2D2 regulate VEGFR2 dynamics and endothelial function.

Applications

Unspecified application

Species

Unspecified reactive species

William R Critchley,Gina A Smith,Ian C Zachary,Michael A Harrison,Sreenivasan Ponnambalam

ACS chemical biology 18:897-904 PubMed36940189

2023

Targeted Protein Degradation through E2 Recruitment.

Applications

Unspecified application

Species

Unspecified reactive species

Nafsika Forte,Dustin Dovala,Matthew J Hesse,Jeffrey M McKenna,John A Tallarico,Markus Schirle,Daniel K Nomura

Nature communications 8:16056 PubMed28685749

2017

The E3 ubiquitin ligase and RNA-binding protein ZNF598 orchestrates ribosome quality control of premature polyadenylated mRNAs.

Applications

Unspecified application

Species

Unspecified reactive species

Aitor Garzia,Seyed Mehdi Jafarnejad,Cindy Meyer,Clément Chapat,Tasos Gogakos,Pavel Morozov,Mehdi Amiri,Maayan Shapiro,Henrik Molina,Thomas Tuschl,Nahum Sonenberg

Nature communications 8:15138 PubMed28469175

2017

Ube2D3 and Ube2N are essential for RIG-I-mediated MAVS aggregation in antiviral innate immunity.

Applications

WB

Species

Human

Yuheng Shi,Bofeng Yuan,Wenting Zhu,Rui Zhang,Lin Li,Xiaojing Hao,She Chen,Fajian Hou

Cell reports 14:1829-40 PubMed26904940

2016

The Spindle Assembly Checkpoint Is Not Essential for Viability of Human Cells with Genetically Lowered APC/C Activity.

Applications

WB

Species

Human

Thomas Wild,Marie Sofie Yoo Larsen,Takeo Narita,Julie Schou,Jakob Nilsson,Chunaram Choudhary
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com